Improvement of dissolution rates of poorly water soluble APIs using novel spray freezing into liquid technology

被引:109
作者
Hu, JH
Rogers, TL
Brown, J
Young, T
Johnston, KP
Williams, RO
机构
[1] Univ Texas, Coll Pharm, Div Pharmaceut, Austin, TX 78712 USA
[2] Univ Texas, Dept Chem Engn, Austin, TX 78712 USA
基金
美国国家科学基金会;
关键词
danazol; carbamazepine; spray freezing into liquid; dissolution; stability;
D O I
10.1023/A:1020390422785
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To develop and demonstrate a novel particle engineering technology, spray freezing into liquid (SFL), to enhance the dissolution rates of poorly water-soluble active pharmaceutical ingredients (APIs). Methods. Model APIs, danazol or carbamazepine with or without excipients, were dissolved in a tetrahydrofuran/water cosolvent system and atomized through a nozzle beneath the surface of liquid nitrogen to produce small frozen droplets, which were subsequently lyophilized. The physicochemical properties of the SFL powders and controls were characterized by X-ray diffraction, scanning electron microscopy (SEM), particle size distribution, surface area analysis, contact angle measurement, and dissolution. Results. The X-ray diffraction pattern indicated that SFL powders containing either danazol or carbamazepine were amorphous. SEM micrographs indicated that SFL particles were highly porous. The mean particle diameter of SFL carbamazepine/SLS powder was about 7 mum. The surface area of SFL danazol/poloxamer 407 powder was 11.04 m(2)/g. The dissolution of SFL danazol/poloxamer 407 powder at 10 min was about 99%. The SFL powders were free flowing and had good physical and chemical stability after being stored at 25degreesC/60% RH for 2 months. Conclusions. The novel SFL technology was demonstrated to produce nanostructured amorphous highly porous particles of poorly water soluble APIs with significantly enhanced wetting and dissolution rates.
引用
收藏
页码:1278 / 1284
页数:7
相关论文
共 30 条
[1]  
Adams T.H, 1982, US Patent, Patent No. [4323478, 4,323,478]
[2]  
ADAMSON AW, 1997, PHYSICAL CHEM SURFAC
[3]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[4]  
[Anonymous], 2001, ELEMENTS XRAY DIFFRA
[5]  
[Anonymous], 1987, Montreal Protocol on Substances That Deplete the Ozone Layer, Final Act
[6]   SOLUBILIZATION AND WETTING EFFECTS OF BILE-SALTS ON THE DISSOLUTION OF STEROIDS [J].
BAKATSELOU, V ;
OPPENHEIM, RC ;
DRESSMAN, JB .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1461-1469
[7]   CLINICAL PHARMACOKINETICS OF CARBAMAZEPINE [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :128-143
[8]  
Briggs A.L, 1976, US Patent No, Patent No. [3932943, 3,932,943]
[9]   Surface treatment of the hydrophobic drug danazol to improve drug dissolution [J].
Brown, S ;
Rowley, G ;
Pearson, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :227-237
[10]   Adsorption of gases in multimolecular layers [J].
Brunauer, S ;
Emmett, PH ;
Teller, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 :309-319